Sfoglia per Rivista RADIOTHERAPY AND ONCOLOGY
Patient position verification: contribution of portal imaging DRR and registration software
2009 S. Pallotta; M. Bucciolini
Patterns of axillary metastases in breast cancer
1986 Ciatto S; Pacini P; Rosselli Del Turco M; Cataliotti L; Cardona G; Carcangiu ML.
PD-0042: APBI versus whole breast irradiation in women age 70 years or older: a subgroup analysis of a phase 3 randomised trial
2015 Meattini, I.; Marrazzo, L.; Saieva, C.; Pallotta, S.; Simontacchi, G.; Scotti, V.; Furfaro, I.; Meacci, F.; Orzalesi, L.; Livi, L.
Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer
2017 Sodergren, S.C., Johnson, C.D., Gilbert, A., Tomaszewski, K.A. ,Chu, W. , Chung, H.T. ,Dennis, K. , Desideri, I. , Glynne-Jones, R. , Gr\onlie Guren, M. ,Kardamakis, D. , Nugent, K. ,Schmidt, H. , Sebag-Montefiore, D. , Vassiliou, V.
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer
2017 Scoccianti, S.; Simontacchi, G.; Talamonti, C.; Marrazzo, L.; Carta, G.A.; Visani, L.; Baki, M.; Poggesi, L.; Greto, D.; Detti, B.; Bonomo, P.; Loi, M.; Pallotta, S.; Livi, L.
PO-0772: Patient-specific realtime error detection for VMAT based on transmission detector measurements
2017 Pasler, M.; Michel, K.; Marrazzo, L.; Obenland, M.; Pallotta, S.; Wirtz, H.; Lutterbach, J.
PO-0801: Large area 2D polycrystalline CVD diamond dosimeter under intensity modulated beams
2016 Talamonti, C.; Baldi, A.; Scaringella, M.; Zani, M.; Pasquini, D.; Pace, E.; Livi, L.; Pallotta, S.; Bruzzi, M.
PO-0811: From gamma passing-rate to DVH: Validation and first clinic applications of a commercial software
2014 Marrazzo, L.; Calusi, S.; Casati, M.; Arilli, C.; Bucciolini, M.
PO-0873: 2D pixelated diamond detector for patient QA in advanced radiotherapy treatments
2018 Bartoli, A.; Scaringella, M.; Baldi, A.; Greto, D.; Scoccianti, S.; Masi, L.; Pallotta, S.; Bruzzi, M.; Talamonti, C.
PO-0949: Advantages and shortcomings of planning hypofractionated lung treatments with VMAT on the average CT
2015 Marrazzo, L.; Casati, M.; Pallotta, S.; Reversi, L.; Bonomo, P.; Simontacchi, G.; Livi, L.; Bucciolini, M.
PO-0978: Testing the C-RAD Catalyst elastic image registration software using a deformable female phantom
2015 Pallotta, S.; Russo, S.; Esposito, M.; Marrazzo, L.; Simontacchi, G.; Bastiani, P.; Paiar, F.; Livi, L.; Bucciolini, M.
PO-0982: Dosimetric comparison between Tomotherapy and Cyberknife for radiosurgery of single brain metastasis
2014 Greto, D.; Pallotta, S.; Masi, L.; Talamonti, C.; Doro, R.; Scoccianti, S.; Marrazzo, L.; Meattini, I.; Bonomo, P.; Livi, L.
Post-irradiation hyperamylasemia as a biological dosimeter.
1992 B. DUBRAY; T. GIRINSKY; H.D. THAMES; A. BECCIOLINI; S. PORCIANI; C. HENNEQUIN; G. SOCIE'; M. BONNAY; J.M. COSSET
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
2010 Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998).
2002 MAGRINI SM; BERTONI F; VAVASSORI V; VILLA S; CAGNA E; MARANZANO E; PERTICI M; PRADELLA R; SPEDIACCI MA; CHIAVACCI A; AMBROSI E; LIVI L; MAGLI A; BELLAVITA R; BOSSI A; G. BITI
Prognostic significance of estrogen receptor determination in primary breast cancer
1988 Ciatto S; Palli D; Iossa A; Pacini P; Cataliotti L; Distante V; Teglia C; Caridi G; Messeri G.
Protective effect of leuprorelin on radiation-induced intestinal toxicity
2013 Monica Mangoni; M. Sottili; C. Gerini; C. Franzese; M. Loi; E. Vanzi; S. Pallotta; L. Livi; D. Bani; G.P. Biti
Proton radiographic and tomographic images from PRIMA experiment.
2013 C. Talamonti; M. Bruzzi; M. Bucciolini; C. Civinini; G. Cuttone; S. Pallotta; N. Randazzo; V. Sipala; M. Scaringella; E. Vanzi
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial
2016 Meattini, I.; Saieva, C.; Desideri, I.; Simontacchi, G.; Marrazzo, L.; Scoccianti, S.; De Luca Cardillo, C.; Scotti, V.; Bonomo, P.; Mangoni, M.; Rossi, F.; Nori, J.; Casella, D.; Bernini, M.; Sanchez, L.; Orzalesi, L.; Pallotta, S.; Bianchi, S.; Livi, L.
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis
2024 Francolini, Giulio; Ghoshal, Arunangshu; Caini, Saverio; Piazzini, Tessa; Becherini, Carlotta; Detti, Beatrice; Di Cataldo, Vanessa; Valzano, Marianna; Visani, Luca; Salvestrini, Viola; Olmetto, Emanuela; Desideri, Isacco; Meattini, Icro; Livi, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Patient position verification: contribution of portal imaging DRR and registration software | 2009 | S. Pallotta; M. Bucciolini | |
| Patterns of axillary metastases in breast cancer | 1986 | Ciatto S; Pacini P; Rosselli Del Turco M; Cataliotti L; Cardona G; Carcangiu ML. | |
| PD-0042: APBI versus whole breast irradiation in women age 70 years or older: a subgroup analysis of a phase 3 randomised trial | 2015 | Meattini, I.; Marrazzo, L.; Saieva, C.; Pallotta, S.; Simontacchi, G.; Scotti, V.; Furfaro, I.; Meacci, F.; Orzalesi, L.; Livi, L. | |
| Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer | 2017 | Sodergren, S.C., Johnson, C.D., Gilbert, A., Tomaszewski, K.A. ,Chu, W. , Chung, H.T. ,Dennis, K. , Desideri, I. , Glynne-Jones, R. , Gr\onlie Guren, M. ,Kardamakis, D. , Nugent, K. ,Schmidt, H. , Sebag-Montefiore, D. , Vassiliou, V. | |
| PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer | 2017 | Scoccianti, S.; Simontacchi, G.; Talamonti, C.; Marrazzo, L.; Carta, G.A.; Visani, L.; Baki, M.; Poggesi, L.; Greto, D.; Detti, B.; Bonomo, P.; Loi, M.; Pallotta, S.; Livi, L. | |
| PO-0772: Patient-specific realtime error detection for VMAT based on transmission detector measurements | 2017 | Pasler, M.; Michel, K.; Marrazzo, L.; Obenland, M.; Pallotta, S.; Wirtz, H.; Lutterbach, J. | |
| PO-0801: Large area 2D polycrystalline CVD diamond dosimeter under intensity modulated beams | 2016 | Talamonti, C.; Baldi, A.; Scaringella, M.; Zani, M.; Pasquini, D.; Pace, E.; Livi, L.; Pallotta, S.; Bruzzi, M. | |
| PO-0811: From gamma passing-rate to DVH: Validation and first clinic applications of a commercial software | 2014 | Marrazzo, L.; Calusi, S.; Casati, M.; Arilli, C.; Bucciolini, M. | |
| PO-0873: 2D pixelated diamond detector for patient QA in advanced radiotherapy treatments | 2018 | Bartoli, A.; Scaringella, M.; Baldi, A.; Greto, D.; Scoccianti, S.; Masi, L.; Pallotta, S.; Bruzzi, M.; Talamonti, C. | |
| PO-0949: Advantages and shortcomings of planning hypofractionated lung treatments with VMAT on the average CT | 2015 | Marrazzo, L.; Casati, M.; Pallotta, S.; Reversi, L.; Bonomo, P.; Simontacchi, G.; Livi, L.; Bucciolini, M. | |
| PO-0978: Testing the C-RAD Catalyst elastic image registration software using a deformable female phantom | 2015 | Pallotta, S.; Russo, S.; Esposito, M.; Marrazzo, L.; Simontacchi, G.; Bastiani, P.; Paiar, F.; Livi, L.; Bucciolini, M. | |
| PO-0982: Dosimetric comparison between Tomotherapy and Cyberknife for radiosurgery of single brain metastasis | 2014 | Greto, D.; Pallotta, S.; Masi, L.; Talamonti, C.; Doro, R.; Scoccianti, S.; Marrazzo, L.; Meattini, I.; Bonomo, P.; Livi, L. | |
| Post-irradiation hyperamylasemia as a biological dosimeter. | 1992 | B. DUBRAY; T. GIRINSKY; H.D. THAMES; A. BECCIOLINI; S. PORCIANI; C. HENNEQUIN; G. SOCIE'; M. BONNAY; J.M. COSSET | |
| Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. | 2010 | Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G | |
| Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998). | 2002 | MAGRINI SM; BERTONI F; VAVASSORI V; VILLA S; CAGNA E; MARANZANO E; PERTICI M; PRADELLA R; SPEDIACCI MA; CHIAVACCI A; AMBROSI E; LIVI L; MAGLI A; BELLAVITA R; BOSSI A; G. BITI | |
| Prognostic significance of estrogen receptor determination in primary breast cancer | 1988 | Ciatto S; Palli D; Iossa A; Pacini P; Cataliotti L; Distante V; Teglia C; Caridi G; Messeri G. | |
| Protective effect of leuprorelin on radiation-induced intestinal toxicity | 2013 | Monica Mangoni; M. Sottili; C. Gerini; C. Franzese; M. Loi; E. Vanzi; S. Pallotta; L. Livi; D. Bani; G.P. Biti | |
| Proton radiographic and tomographic images from PRIMA experiment. | 2013 | C. Talamonti; M. Bruzzi; M. Bucciolini; C. Civinini; G. Cuttone; S. Pallotta; N. Randazzo; V. Sipala; M. Scaringella; E. Vanzi | |
| PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial | 2016 | Meattini, I.; Saieva, C.; Desideri, I.; Simontacchi, G.; Marrazzo, L.; Scoccianti, S.; De Luca Cardillo, C.; Scotti, V.; Bonomo, P.; Mangoni, M.; Rossi, F.; Nori, J.; Casella, D.; Bernini, M.; Sanchez, L.; Orzalesi, L.; Pallotta, S.; Bianchi, S.; Livi, L. | |
| Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis | 2024 | Francolini, Giulio; Ghoshal, Arunangshu; Caini, Saverio; Piazzini, Tessa; Becherini, Carlotta; Detti, Beatrice; Di Cataldo, Vanessa; Valzano, Marianna; Visani, Luca; Salvestrini, Viola; Olmetto, Emanuela; Desideri, Isacco; Meattini, Icro; Livi, Lorenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile